GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » uniQure NV (FRA:UQ1) » Definitions » Future Policy Benefits

uniQure NV (FRA:UQ1) Future Policy Benefits


View and export this data going back to 2014. Start your Free Trial

What is uniQure NV Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


uniQure NV (FRA:UQ1) Business Description

Traded in Other Exchanges
Address
Paasheuvelweg 25, Amsterdam, NH, NLD, 1105 BP
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.